Acquisition by Campagna Jason of 70687 shares of Q32 Bio at 16.82 subject to Rule 16b-3
| QTTB Stock | 25.44 0.89 3.63% |
About 54% of Q32 Bio's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Q32 Bio suggests that some traders are interested. The current market sentiment, together with Q32 Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Q32 Bio stock news signals to limit their universe of possible portfolio assets.
Q32 |
Filed transaction by Q32 Bio Officer Chief Medical Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Q32 Bio's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Q32 Bio's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Q32 Bio Fundamental Analysis
We analyze Q32 Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Q32 Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Q32 Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Q32 Bio is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Q32 Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Q32 Bio stock to make a market-neutral strategy. Peer analysis of Q32 Bio could also be used in its relative valuation, which is a method of valuing Q32 Bio by comparing valuation metrics with similar companies.
Peers
Q32 Bio Related Equities
| WSC | Willscot Mobile | 6.67 | ||||
| CTOS | Custom Truck | 2.80 | ||||
| RLX | RLX Technology | 1.67 | ||||
| UVV | Universal | 1.58 | ||||
| ISPR | Ispire Technology | 0.81 | ||||
| COCO | Vita Coco | 0.61 | ||||
| ABEV | Ambev SA | 0.91 |
Complementary Tools for Q32 Stock analysis
When running Q32 Bio's price analysis, check to measure Q32 Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Q32 Bio is operating at the current time. Most of Q32 Bio's value examination focuses on studying past and present price action to predict the probability of Q32 Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Q32 Bio's price. Additionally, you may evaluate how the addition of Q32 Bio to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |